Trusted Resources: Evidence & Education
Scientific literature and patient education texts
TED Is Separate and Distinct From Graves ’ Disease, and Requires Different Treatment
source: TEDimpact.com
year: 2023
summary/abstract:TED is a heterogeneous condition, meaning symptoms may vary from patient to patient.
Some symptoms of TED, such as eye redness, excessive tearing, grittiness and foreign body sensation, and photophobia/light sensitivity, could be misdiagnosed as Dry Eye Disease (DED). DED results from an insufficient lubrication to the eye’s aqueous tear film layer due to insufficient tear production or evaporation loss. DED is commonly addressed with treatments such as artificial tears or gels; however, more severe cases may result in surgery.
Given the similarity in presentation, it is important for all eye care specialists to be aware of TED and to evaluate patients, especially those who may have preexisting thyroid conditions, for both. Here are some additional questions that can help determine if your patient needs to see a TED Specialist for a baseline eye exam:
- Do you have or have you recently developed any new thyroid conditions?
- Do you have or have you experienced any pain behind your eye?
- Do your eyes have restriction of movement?
- Have you experienced any blurry vision?
- Have you experienced double vision?
- Do you often think about your eyes?
- Do your eyes look, work, or feel differently than they used to?
- How has the appearance of your eyes changed (if TED is already suspected)?
Disclaimer:Horizon supports the mission of oneGRAVESvoice and has provided financial support for this platform. Horizon neither owns or controls this platform, and unless expressly stated otherwise, does not have editorial control over content or responsibility for any other information or services.
read moreRelated Content
-
Graves’ and Thyroid Eye Disease Support Group MeetingThis event is hosted by Graves' Dise...
-
Dealing With Thyroid Eye Disease: Patient and Physician PerspectivesJoin us for a webinar hosted by the Grav...
-
Pathogenesis of Thyroid Eye Disease: Review and Update on Molecular MechanismsOrbital changes in thyroid orbitopathy (...
-
New York Walk & Public ForumWe walk to raise awareness, and to honor...
-
Teprotumumab for Treatment of Thyroid Eye Disease Meets Endpoints in Phase 3 StudyResults from the phase 3 OPTIC study sho...
-
ASOPRS 2023 Fall Scientific SymposiumThe American Society of Ophthalmic Pla...
-
Clinical Characteristics of Patients Requiring a Second Dose of Radioactive Iodine for the Treatment of Graves’ Di...Graves’ disease is an autoimmune condi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.